Bipolar Disorders: Mixed States, Rapid-Cycling, and Atypical Forms

129 Recurrent brief depressionMarneros, A., Deister, A., and Rohde, A. (1991). Affektive, schizoaffektive und schizophrenePsychosen. Eine vergleichende Langzeitstudie. [Affective, Schizoaffective and SchizophrenicDisorders: A Comparative Long-Term Study.] Berlin: Springer.Meier, R. (1985). Katamnese von 40 jugendlichen Patienten nach einem Suizidversuch beiverschiedenen Behandlungsmöglichkeiten im Anschluss an eine somatische Klinik. Inauguraldissertation, Med. Diss. Zurich: University of Zurich.Merikangas, K., Wicki, W., and Angst, J. (1990). Combined Depression. Royal College ofPsychiatrists Annual Meeting 1990. Birmingham, p. 54.Montgomery, S. A. (1997). Suicide and antidepressants. Ann. N. Y. Acad. Sci., 836, 329–38.Montgomery, S. A., Montgomery, D., and Baldwin, D. (1989). Intermittent 3-day depressionsand suicidal behaviour. Neuropsychobiology, 22, 128–34.Montgomery, D. B., Roberts, A., and Green, M. (1994). Lack of efficacy of fluoxetine inrecurrent brief depression and suicidal attempts. Eur. Arch. Psychiatry Clin. Neurosci. 244,211–15.Paskind, H. A. (1929). Brief attacks of manic-depressive depressions. Arch. Neurol. Psychiatry,22, 123–34.Paskind, H. A. (1930). Manic-depressive psychosis as seen in private praxis. Length of the attackand length of the interval. Arch. Neurol. Psychiatry, 23, 789–94.Pazzaglia, P. J., Post, R. M., and Ketter, T. A. (1993). Preliminary controlled trial of nimodipinein ultra-rapid cycling affective dysregulation. Psychiatry Res., 49, 257–72.Pazzaglia, P. J., Post, R. M., Ketter, T. A. et al. (1998). Nimodipine monotherapy and carbfamazepineaugmentation in patients with refractory recurrent affective illness. J. Clin.Psychopharmacol., 18, 404–13.Pezawas, L., Stamenkovic, M., and Aschauer, N. (2002a). Successful treatment of recurrent briefdepression with reboxetine – a single case analysis. Pharmacopsychiatry, 35, 75–6.Pezawas, L., Stamenkovic, M., and Jagsch, R. (2002b). A longitudinal view of triggers andthresholds of suicidal behavior in depression. J. Clin. Psychiatry, 63, 866–73.Pezawas, L., Wittchen, H. U., and Pfister, H. (2003). Recurrent brief depressive disorderreinvestigated: a community sample of adolescents and young adults. Psychol. Med., 33,407–18.Pfortmüller, J. (1983). Beitrag zur Validierung des Depressionsratings im Fragebogen SPIKE IV anpsychiatrisch hospitalisierten Patienten. Inaugural dissertation, Med. Diss. Zurich: Universityof Zurich.Post, R. M., L’Herrou, T., and Luckenbaugh, D. A. (1998). Statistical approaches to trial durationsin episodic illness. Psychiatry Res., 78, 71–87.Stamenkovic, M., Pezawas, L., and De Zwaan, M. (1998). Mirtazepine in recurrent briefdepression. Int. Clin. Psychopharmacol., 13, 39–40.Stamenkovic, M., Blasbichier, T., Riederer, F. et al. (2001). Fluoxetine treatment in patients withrecurrent brief depression. Int. Clin. Psychopharmacol., 16, 221–6.Staner, L., De La Fuente, J. M., and Kerkhofs, M. (1992). Biological and clinical features ofrecurrent brief depression: a comparison with major depressed and healthy subjects. J. Affect.Disord., 26, 241–6.